TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 34 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,201,000 | -21.9% | 670,459 | +7.0% | 0.55% | -32.5% |
| Q4 2020 | $9,220,000 | +0.5% | 626,759 | -2.9% | 0.82% | -9.2% |
| Q3 2020 | $9,172,000 | -3.8% | 645,435 | -45.2% | 0.90% | +0.4% |
| Q2 2020 | $9,533,000 | +87.2% | 1,178,346 | -6.5% | 0.90% | +40.8% |
| Q1 2020 | $5,093,000 | +160.5% | 1,260,694 | +852.9% | 0.64% | +100.3% |
| Q3 2016 | $1,955,000 | +64.6% | 132,300 | 0.0% | 0.32% | +3.2% |
| Q2 2016 | $1,188,000 | -2.9% | 132,300 | 0.0% | 0.31% | +16.2% |
| Q1 2016 | $1,224,000 | -26.6% | 132,300 | 0.0% | 0.26% | +8.6% |
| Q4 2015 | $1,668,000 | -12.9% | 132,300 | -10.0% | 0.24% | 0.0% |
| Q3 2015 | $1,915,000 | -40.3% | 147,000 | 0.0% | 0.24% | -22.3% |
| Q2 2015 | $3,208,000 | +66.9% | 147,000 | +54.7% | 0.31% | +57.0% |
| Q1 2015 | $1,922,000 | – | 95,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |